Hematologic and Immune systems Flashcards

Exam 4 (Final)

1
Q

Human Immunodeficiency Virus Infection:

What is it ?

A

Impaired cellular immunity is a consequence of AIDS.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Human Immunodeficiency Virus Infection:

What is AIDS caused by?

A

AIDS is caused by HIV.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Human Immunodeficiency Virus Infection:

What is it defined as?

A

Now defined as a chronic illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Human Immunodeficiency Virus Infection

Epidemiology: How many people with 1.2 million? How many people are living with it unaware? What pop is it higher in?

A

CDC estimated more than 1.2 million people with AIDS.

1 in 7 living with HIV but unaware

Higher in African Americans/Blacks

Higher in men who have sex with men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Stages of HIV Infection

A

Stage 1: CD4 T-cells count > 500 mcL

Stage 2: CD4: 200-499

Stage 3: AIDS with CD4 < 200 mcL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Stages of HIV Infection

What is management?

A

Control of opportunistic infection

Antiretroviral therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Human Immunodeficiency Virus Infection

Pathogenesis:

A

CD4 binding site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Anemias:

Broad anemia groups:

A

Blood loss anemia

Hemolytic anemias

Deficiency anemias

Chronic anemia

Aplastic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Anemias:

Hemolytic anemias include

A

Congenital hemolytic anemia

Acquired hemolytic anemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Anemias:

Deficiency anemias include:

A

Iron deficiency anemia

Megaloblastic anemias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Anemias:

Aplastic anemias: what to know?

A

bone marrow is generating new cells.. 70% mortality rate w/i one year if not treated w blood transfusions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Anemias Assessment:

What should you assess for?

A

Assess for blood loss.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Anemias Assessment:

What mind problems to assess?

A

Weakness, depressed mood, impaired cognitive function, and easy fatigability

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anemias Assessment:

What body problems to assess?

A

At risk for impaired tissue oxygenation, impaired organ function, impaired susceptibility to thrombocytopenic bleeding, increased risk of postoperative mortality, increased probability of transfusion, and decreased survival

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Anemias:

Physical Examination and management

A

Pallor, tachycardia, hypotension

Splenomegaly, jaundice, and dark urine

Intake and output

Stool guaiac test

Low serum iron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Stool guiac test:

A

detects hidden blood in stool samples.

bluish color says there is blood

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Anemias: Physical Examination and management

Management: What two things to do?

A

Parenteral iron sulfate

Blood transfusion

18
Q

Anemias:

Physical Examination and management:
Blood transfusion: When is this done?

A

When risks of decreased oxygen-carrying capacity outweigh the risks of transfusion

19
Q

Nursing Care of the Patient With Anemia:

What are you assessing for?

A

Assess for adverse effects of replacement therapy.

Assess signs and symptoms indicative of decreased perfusion.

20
Q

Nursing Care of the Patient With Anemia:

What should you identify?

A

Identify the correct patient and ensure ABO compatibility.

21
Q

Nursing Care of the Patient With Anemia:

What should you decrease?

A

Decrease metabolic needs and reduce oxygen demand.

22
Q

Nursing Care of the Patient With Anemia:

What kind of strategies should you implement?

A

Implement strategies to reduce phlebotomy blood loss.

23
Q

Disorders of Hemostasis:

What are they?

A

Platelet disorders

24
Q

Disorders of Hemostasis:

Platelet disorders
Types of thrombocytopenia- What are they?

A

Drug-induced thrombocytopenia

Heparin-induced thrombocytopenia

Thrombotic thrombocytopenic purpura (TTP)

Immune thrombocytopenic purpura (ITP)

25
Q

Disorders of Hemostasis:

Assessment and Management:

What are you assessing for (symptom-association)

A

Assessment of symptoms associated with any of the risk factors or associated disorders

26
Q

Disorders of Hemostasis:

Assessment and Management:

What are you assessing for (symptoms)

A

Fatigue, fever, weight loss, or night sweats

27
Q

Disorders of Hemostasis:

Assessment and Management:

What history are you collecting?

A

Accurate medication and alcohol history

28
Q

Disorders of Hemostasis:

Assessment and Management:
Management: When should you hold drugs? What drugs to avoid?

A

Hold any drugs that may induce thrombocytopenia such as anticonvulsants, penicillin.

Avoid aspirin, antiplatelet agents, and NSAIDs.

29
Q

Disorders of Hemostasis:

Assessment and Management:
Management: What else should you avoid?

A

Avoid trauma.

30
Q

Disorders of Hemostasis:

Assessment and Management:
Management: What kind of transfusions should you get?

A

Platelet transfusions

31
Q

Disorders of Hemostasis:

Assessment and Management:
Management: What should you do daily?

A

Daily labs

32
Q

Disorders of Hemostasis:

Disseminated Intravascular Coagulation:

What is it?

A

Imbalance between the natural procoagulant and anticoagulant systems

33
Q

Disorders of Hemostasis:

Disseminated Intravascular Coagulation:

What occurs in this

A

Unregulated thrombin activity, microvasculature thrombi, platelet consumption, and microangiopathic hemolytic anemia

34
Q

Disorders of Hemostasis:

Disseminated Intravascular Coagulation:

Etiology: What kind of complication is it?

A

DIC is a secondary complication.

35
Q

Disorders of Hemostasis:

Disseminated Intravascular Coagulation:

Etiology: What is extrinsic pathway activated by?

A

Extrinsic pathway is activated by damage to the endothelial lining of blood vessels.

36
Q

Disorders of Hemostasis:

Disseminated Intravascular Coagulation:

Etiology: What is intrinsic pathway activated by?

A

Intrinsic pathway is activated when subendothelial tissue is exposed to the bloodstream and circulating factor XII comes in contact with the exposed tissue.

37
Q

Disorders of Hemostasis:

Disseminated Intravascular Coagulation:

Assessment
Clinical presentation

A

Systemic ischemia from the thrombi formation

Minor or major hemorrhage

38
Q

Disorders of Hemostasis:

Disseminated Intravascular Coagulation:

Assessment: What do you collect?

A

Complete history

39
Q

Disorders of Hemostasis:

Disseminated Intravascular Coagulation:

Assessment: How is presentation?

A

Acute or chronic presentation

Low-grade bleeding

Bleeding from the nose, gums, lungs, gastrointestinal tract, surgical sites, injection sites, and intravascular access sites; hematuria; petechial rashes; and purpura fulminans

40
Q

Disorders of Hemostasis:

Disseminated Intravascular Coagulation:

Assessment: How is presentation?

A

Unexpected thrombotic events

Signs and symptoms of inappropriate clotting

Demarcation cyanosis

41
Q

Disorders of Hemostasis:

Disseminated Intravascular Coagulation:
Management:

What to eliminate? What to treat sepsis? What kind of therapy? What else?

A

Eliminate the causative agent.

Antibiotic or antifungal therapy for sepsis

Fluid replacement

Oxygen

Heparin therapy

Replacement therapy- Fresh Frozen Plasma (FFP,) RBC

42
Q
A